Skip to main content
. 2010 Mar 19;76(10):3082–3088. doi: 10.1128/AEM.00155-10

FIG. 4.

FIG. 4.

Homologous and heterologous BBMV competition binding assay results obtained with (A) biotinylated chymotrypsin-treated mCry3A (c-mCry3A) and (B) biotinylated chymotrypsin-treated eCry3.1Ab (c-eCry3.1Ab) labeled proteins. The Western blots show the effects of using buffer alone (Ø) and a 100-fold molar excess of unlabeled proteins during BBMV incubation (A) or the effects of using buffer alone (Ø) and a 75-fold molar excess of unlabeled proteins (B).